期刊文献+

晚期糖基化终产物在糖尿病血管并发症中的作用机制 被引量:4

Mechanism of action advanced glycation end products contribute to the development of diabetic vascular complications
下载PDF
导出
摘要 晚期糖基化终产物(AGEs)是蛋白质或脂质经过糖基化反应的产物。AGEs存在于糖尿病患者的血管中,促进动脉粥样硬化的发展。多种不同的细胞上AGEs的存在和聚集影响着细胞内外的结构和功能。AGEs通过与细胞外基质基底膜上的分子形成交联和与其受体(RAGE)结合引起多种微血管和大血管并发症。RAGE被AGEs激活后导致转录因子NF-κB和它的靶因子的表达。AGEs可诱发糜蛋白酶的表达和糜蛋白酶依赖性血管紧张素Ⅱ的生成,从而作用于糖尿病血管并发症的发展。 Advanced glycation end products (AGEs) are proteins or lipids that become glycated after exposure to sugars. AGEs are prevalent in the diabetic vasculature and contribute to the development of atherosclerosis. The presence and accumulation of AGEs in many different cell types affect extracellular and intracellular structure and function. AGEs contribute to a variety of microvascular and macrovascular complications through the formation of cross-links between molecules in the basement membrane of the extracellular matrix and by engaging the receptor for advanced glycation end products (RAGE). Activation of RAGE by AGEs causes upregulation of the transcription factor nuclear factor-κB(NF-κB) and its target genes. AGEs can induce chymase expression and chymase-dependent angiotensin Ⅱ generation,and contribute to the development of diabetic vascular complications.
出处 《实用心脑肺血管病杂志》 2007年第6期478-481,共4页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 糖基化终产物 血管并发症 糖尿病 Advanced glycation end products Vascular complications Diabetes mellitus
  • 相关文献

参考文献34

  • 1Ulrich P,Cerami A.Protein glycation,diabetes,and aging.Recent Prog Horm Res,2001,56:1-21.
  • 2Garay-Sevilla ME,Regalado JC,Malacara JM,et al.Advanced glycosylation endproducts in skin,serum,saliva and urine and its association with complications of patients with type 2 diabetes mellitus.J Endocrinol Invest,2005,28:223-230.
  • 3Rojas A,Morales MA.Advanced glycation and endothelial functions:a link towards vascular complications in diabetes.Life Sci,2004,76:715-730.
  • 4Vlassara H,Fuh H,Donnelly T,et al.Advanced glycation end products promote adhesion molecule (VCAM-1,ICAM-1) expression and atheroma formation in normal rabbits.Mol Med,1995,1(4):447-456.
  • 5Forbes JM,Yee LT,Thallas V,et al.Advanced glycation end product interventions reducediabetes acceler atedatherosclerosis.Diabetes,2004,53:1813-1823.
  • 6Schmidt AM,Hori O,Chen JX,et al.Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice:a potential mechanism for the accelerated vasculopathy of diabetes.J Clin Invest,1995,96:1395-1403.
  • 7Hammes HP,Weiss A,Hess S,et al.Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina.Lab Invest,1996,75:325-338.
  • 8Throckmorton DC,Brogden AP,Min B,et al.PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products.Kidney Int,1995,48:111-117.
  • 9Tsilibary EC,Charonis AS,Reger LA,et al.The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC-1 domain to type Ⅳ collagen.J Biol Chem,1988,263:4302-4308.
  • 10Paul RG,Bailey AJ.The effect of advanced glycation end product formation upon cell matrix interactions.Int J Biochem Cell Biol,1999,31:653-660.

二级参考文献10

  • 1Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, et al.Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis, 1998, 141(1): 61-75.
  • 2Cipollone F, Iezzi A, Fszia M, Zucchelli M, Pini B, Cuccurullo C, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation, 2003, 108(9): 1070-077.
  • 3Bierhaus A, Illmer T, Kssper M, Luther T, Quehenberger P, Tritschler H, et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cell is dependent on RAGE. Circulation, 1997, 96(7):2262-271.
  • 4Todd B, Galina S, Peter L. The nuclear factor κB signaling pathway participates in dysregultion of vascular smooth muscle cell in vitro and in human atherosclerosis. J Bio Chem, 1997, 272(25): 15817-824.
  • 5Zieman S, Kass D. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail,2004, 10(3): 144-151.
  • 6Bssta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, et al.Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation, 2002, 105(7): 816-822.
  • 7Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophy, Acta, 2000,1498(2-3): 99-111.
  • 8Kang JL, Pack IS, Hong SM, Lee HS, Castranova V. Silica induces nuclear factor-kappa B activation through tyrosine phosphorylation of I kappa B-alpha in RAW264.7 macrophages. Toxicol Appl Phamacol, 2000, 169(1): 59-65.
  • 9Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia, 2001, 44(2): 129-146.
  • 10徐红新,李建军,李庚山.核因子-κB与动脉粥样硬化[J].中国动脉硬化杂志,2001,9(2):179-181. 被引量:15

共引文献14

同被引文献61

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部